These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15494157

  • 1. Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.
    Yukuhiro N, Kimura H, Nishikawa H, Ohkawa S, Yoshikubo S, Miyamoto M.
    Brain Res; 2004 Nov 19; 1027(1-2):59-66. PubMed ID: 15494157
    [Abstract] [Full Text] [Related]

  • 2. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.
    Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S.
    Sleep; 2004 Nov 01; 27(7):1319-25. PubMed ID: 15586784
    [Abstract] [Full Text] [Related]

  • 3. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K, Shintani Y, Hirai K, Yoshikubo S.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):855-63. PubMed ID: 19556449
    [Abstract] [Full Text] [Related]

  • 4. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
    Arbon EL, Knurowska M, Dijk DJ.
    J Psychopharmacol; 2015 Jul 01; 29(7):764-76. PubMed ID: 25922426
    [Abstract] [Full Text] [Related]

  • 5. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Jul 01; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 6. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A, Rousset C, Millan MJ, Spedding M, Delagrange P, Cespuglio R.
    Psychopharmacology (Berl); 2009 Jul 01; 205(1):93-106. PubMed ID: 19370342
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep 01; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW, Suess PE, Griffiths RR.
    Arch Gen Psychiatry; 2006 Oct 01; 63(10):1149-57. PubMed ID: 17015817
    [Abstract] [Full Text] [Related]

  • 11. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.
    Roth T, Stubbs C, Walsh JK.
    Sleep; 2005 Mar 01; 28(3):303-7. PubMed ID: 16173650
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G, Bedini A, Lucarini S, Mor M, Rivara S.
    Expert Opin Drug Metab Toxicol; 2015 Jul 01; 11(7):1145-56. PubMed ID: 25956235
    [Abstract] [Full Text] [Related]

  • 13. Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.
    Miyamoto M.
    Neurosci Lett; 2006 Jul 24; 402(3):201-4. PubMed ID: 16730121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.
    Seibt J, Aton SJ, Jha SK, Coleman T, Dumoulin MC, Frank MG.
    Sleep; 2008 Oct 24; 31(10):1381-91. PubMed ID: 18853935
    [Abstract] [Full Text] [Related]

  • 16. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
    Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, Mathes AM.
    Crit Care Med; 2014 Jan 24; 42(1):e22-31. PubMed ID: 24145838
    [Abstract] [Full Text] [Related]

  • 17. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
    Wang-Weigand S, McCue M, Ogrinc F, Mini L.
    Curr Med Res Opin; 2009 May 24; 25(5):1209-13. PubMed ID: 19327100
    [Abstract] [Full Text] [Related]

  • 18. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr 24; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 19. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
    Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M.
    Neuropharmacology; 2005 Feb 24; 48(2):301-10. PubMed ID: 15695169
    [Abstract] [Full Text] [Related]

  • 20. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G.
    J Pharmacol Exp Ther; 1986 May 24; 237(2):649-58. PubMed ID: 2871178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.